




High concentrations of pharmaceuticals in a Nigerian river catchment

Olatayo M. Ogunbanwoa, Paul Kaya, Alistair B. Boxallb, John Wilkinsonb, Chris J. Sinclairc, Rasheed A. Shabid, Abolaji E. Fasasid , Gregory A. Lewisd , Olanrewaju A. Amodad and Lee E. Browna

a School of Geography/water@leeds, University of Leeds, Leeds, West Yorkshire, LS2 9JT, UK
bEnvironment Department, University of York, Heslington, York, North Yorkshire, YO10 5NG, UK
cEcoChemistry Section, FERA Science Ltd, Sand Hutton, York, North Yorkshire, YO41 1LZ, UK
dLagos State Environmental Protection Agency (LASEPA), Governor’s Road, Secretariat Alausa, Lagos State, Southwest Nigeria.





Pharmaceutical contamination of the environment is recognized as a global problem although work has focused on Europe and North America to date and there remains a dearth of information for developing countries, including those in Africa. To address this data gap the occurrence of thirty-seven pharmaceuticals belonging to nineteen therapeutic classes was monitored in surface water and effluent in Lagos State, Southwest Nigeria. Samples were collected quarterly from twenty-two sites and twenty-six compounds were detected at least once, many in the micrograms per litre range. Maximum concentrations for those compounds detected ranged from 75 to 129 µg L-1 and even mean concentrations for thirteen compounds were in the order of µg L-1. These values are amongst the highest ever measured globally. 
Sewage effluent was more important than drug manufacturing waste in polluting rivers although there are likely to be numerous unregulated sources of effluent being discharged to rivers which require further study, including urban waste collection areas and vacuum trucks which collect effluent. Seasonal trends in the data were complex with some compounds being found at higher concentrations in the dry season and, conversely, others being greater during the wet period, this variation potentially relating to the variety of pollution sources in the catchment. Pharmaceuticals are indispensable to human health although their usage and discharge into the aquatic environment may lead to ecological problems and antibiotic resistance. The data presented in this paper indicate that pharmaceutical pollution of freshwaters is a serious issue in Nigeria and management efforts are needed to ameliorate this issue.









The pharmaceuticals monitored (Table 1) were chosen based on their expected presence in surface waters (Burn et al., 2018), being high-use drugs that have been found previously in rivers around the world (Hughes et al., 2013).

2.2. Study catchment





Table 1. Physico-chemical properties of the pharmaceutical compounds monitored in the Odo Iya Alaro river, Lagos, Nigeria (www.drugbank.ca)	
Therapeutic Group	Compound	LogKow	pKa	Molecular Wgt (g ml-1)	Formula	Solubility (mg L-1)





































n/a = not available; Wgt =Weight						

      
Figure 1. The Odo-Iya Alaro river in Lagos State, Southwest Nigeria and the twenty-two sampling stations used in the current study. 
             
         

2.3. Sample collection
Effluent and surface water samples were collected on a quarterly basis to incorporate both the wet (April and July) and dry seasons (October and January). Amber glass sampling vessels were rinsed with 100% methanol once and deionised water three times to remove potential contamination before sampling. Samples were collected at the same time of day and location, checked using a Global Positioning System (GPS). At each sampling site, three 50 mL water samples were collected and then homogenised into a single 150 mL composite sample. A 10 mL aliquot of each composite sample was then filtered on site through a Whatman GFF (0.7 µm pore size) glass microfiber syringe filter into a 20 mL amber glass vial with a Teflon-lined screw cap (Fisher Scientific, UK). Samples were frozen immediately with dry ice before shipping within 24 hrs to the UK for analysis. On arrival (three days), samples were thawed immediately and analysed. 
2.4 Chemical analysis
Quantification of pharmaceutical concentrations was achieved using HPLC-MS/MS with a Thermo Scientific TSQ Endura Mass spectrometer coupled with an UltiMate 3000 liquid chromatograph. The method used was adapted from Furlong et al. (2014) and further validated (Burns et al., 2018). Briefly, prior to starting the quantitative analysis, 500 µL of each water sample was diluted with 495 µL of HPLC-grade water and spiked with 5 µL of a mixture of internal standards (each at a concentration of 80 µg L-1) in glass autosampler vials. The 50 % dilution was done in order to clean the samples and bring analyte concentrations to within the calibrated range. Where concentrations were found to still exceed the calibrated range further dilution and reanalysis was carried out. A random number generator was used to randomise the order in which samples were injected onto the HPLC-MS/MS. Analysis was conducted by direct injection of 100 µL of each sample into a Phenomenex Eclipse Plus C18 chromatography column using a Phenomenex C18 (ODS, Octadecyl) 4 mm x 3 mm ID guard column. Mobile phase A was HPLC-grade water with 0.01 M formic acid and 0.01 M ammonium formate while mobile phase B was 100 % HPLC-grade methanol. A flow rate of 0.45 mL min-1 was used with a gradient starting at 10 % B which then increased to 40 % at 5 min, 60 % at 10 min, 100 % at 15 min, and remaining 100 % B until 23 min then dropping to 10 % at 23 min prior to a re-equilibration. The autosampler temperature was kept at 4C and the HPLC column compartment at 40C. The collision gas was argon at a pressure of 2 mTorr. Quantification was done with a 16-point calibration using deuterated internal standards (Burns et al., 2018) ranging from 1 to 32000 ng L-1 and calibration r2-values were consistently >0.95. Analytical limits of detection were calculated as described by Burns et al. (2018) and ranged from 0.9 ng L -1 (carbamazepine) to 12.4 ng L-1 (gabapentin) (Table S2). Quality control (QC) measures were used throughout the analysis; briefly, method blanks (n=6) were made with an identical collection procedure as the environmental samples although using HPLC-grade water. Concentrations of the target pharmaceuticals were consistently below levels of analytical quantification in the method blanks. Additionally, QCs consisting of all target pharmaceuticals at a concentration of 80 ngL-1 were injected after every 4 samples followed by an instrumental blank consisting of pure HPLC-grade water. Analytical tolerance was consistently within ±15 % and the instrumental blanks did not contain detectable residues of the target analytes. 
2.5 Data analysis




All of the study compounds were detected although the frequency of detection varied greatly for different substances (Figure 2). Some, including carbamezapine, fexofenadine and paracetamol, were present in sewage effluent and surface waters most of the time whereas others, such as diltiazem, propranolol and venlafaxine, were rarely detected. Detection frequencies in pharmaceutical manufacturing effluent were significantly lower than in sewage effluent and river water (GLM: χ2 (3) = 883.32, p <0.001).

Figure 2. Detection frequencies for pharamceuticals measured in sewage effluent, pharmaceutical manufacturing waste and rivers (urban and semi-urban).
  
3.2 Pharmaceutical concentrations
Peak pharmaceutical concentrations were in the range of hundreds of micrograms per litre while mean concentrations were several orders of magnitude lower (Figure 3). The antibiotic sulfamethoxazole was detected at the highest concentration of 129.4 µg L-1 whilst paracetamol was also measured at 111.4 µg L-1. Paracetamol and sulfamethoxazole also had the highest mean concentrations of 18.2 and 11.2 µg L-1 respectively. Many other compounds were found at concentrations only slightly lower than these including cimetidine, fexofenadine, carbamazepine, metformin, diazepam, atenolol, trimethoprim, and codeine (Table S3). 

Figure 3. Pharmaceutical concentrations measured in the Odo Iya Alaro river catchment, Lagos, Nigeria. Boxes represent median and 25th and 75th percentiles whilst whiskers show minimum and maximum values.

There was a significant difference in pharmaceutical concentrations in the different matrices sampled (GLM: χ2 (3) = 883.32, p <0.001). When pharmaceuticals were detected in manufacturing effluent concentrations tended to be higher than in sewage effluent and river water. Drugs were diluted slightly after sewage effluent had entered urban rivers although concentrations were lower still in semi-urban reaches. Although detection frequencies were generally higher in the wet season, concentrations were often higher in the dry season (Figure 4).





Pharmaceuticals are biologically active and pseudo-persistent in the environment due to the continual input of wastewater effluent to rivers (Hughes et al., 2013; Kay et al., 2017; Burns et al., 2018) and, therefore, potentially pose a toxicological risk to non-target organisms (Boxall et al., 2002; Huang et al., 2012). Monitoring has mainly taken place in Europe and the United States though and data are severely lacking for developing countries, such as those in Africa. This paper addresses this important research gap by presenting new information about the presence of pharmaceuticals in pharmaceutical manufacturing effluent, sewage effluent and surface water in Lagos, Nigeria, a country which has been studied very little. 
The detection of twenty-six pharmaceuticals in the Odo Iya Alaro river confirmed the presence of these substances in Nigerian watercourses including some that have not previously been observed in African rivers more widely. These were from a wide range of therapeutic classes including anti-inflammatories, antidepressants and antihistamines, and were present at relatively high concentrations compared to some other drugs that were measured. Pseudo-persistence was observed, presumably due to continuous discharge of effluents to the river, similar to that found in other studies. One of the key findings of the current study is that pharmaceutical concentrations in the environment are often two to three orders of magnitude higher than typically reported in Europe and the US where most monitoring has been undertaken (Verlicchi et al. 2012; Hughes et al., 2013; Aus der Beek et al., 2016; Madikizela et al., 2017; Burns et al., 2018). Some of the highest pharmaceutical concentrations ever found in rivers globally have been reported in this paper, it not being uncommon to have measured levels in the tens of micrograms per litre range up to 129 µg L-1. This is in-line with findings in Kenya ((K’Oreje et al., 2012, 2016, 2018). Particular compounds of concern in the Nigerian environment appear to be carbamezapine, cimetidine, fexofenadine, metformin, paracetamol and sulfamethoxazole. The presence of a range of substances at such high concentrations may be attributed to a range of factors including over-the-counter sales, differences in health issues, poorer removal efficiencies at wastewater treatment plants, unregulated discharges by pharmaceutical manufacturing companies, and illegal disposal of sewage by vacuum trucks. Other workers have proposed that these sources are likely to be important in Africa (Fekadu et al., 2019) and further study is needed to disentangle inputs from these various sources.
There were few spatial trends observed in pharmaceutical pollution in this study which appears to be ubiquitous although the absence of many compounds in pharmaceutical production effluent suggests that sewage effluent is the main source of pollution. Indeed, the occurrence and concentrations of pharmaceuticals in wastewater treatment plant effluent and surface water were very similar. This highlights that receiving waters have little capacity to dilute effluent but also that further unregulated and unmonitored sources of effluent may be discharging to the river, such as vacuum trucks collecting effluent in urban areas. Other work in India has however proposed that pharmaceutical production facilities are a key source of pharmaceutical pollution developing countries (Balakrishna et al., 2017).
Although season had an impact on pharmaceutical pollution a complex picture exists with some compounds being found at extremely high concentrations in the dry season and, conversely, others being relatively high during the wet season. Previous studies have proposed a range of reasons for variation across the year, including seasonal usage and changes in environmental conditions (e.g. temperature and river flow) (Tewari et al., 2013; Kolpin et al., 2014; Fekadu et al., 2019). It may be that the multiple sources of pharmaceuticals in the catchment results in the complexity of spatial patterns found in the current study, with some continuous effluent discharges being diluted in the wet season but other sources (e.g. urban waste sites) having pollutants mobilised in periods of rainfall.
5. Conclusion









Adegun, O. Odunuga O., Appia, Y.(2015).  Environmental change and ecological services in system 1 drainage area of Lagos. Environ and earth sc, 5 (17).
Agunbiade, F.O., Moodley, B., 2014. Pharmaceuticals as emerging organic contaminants in Umgeni River water system, KwaZulu-Natal, South Africa. Environ. Monit. 
            Assess. 44, 7273-7291.
Agunbiade,F.O., Moodley, B. (2016). Occurrence and distribution pattern of acidic pharmaceuticals in surface water, wastewater, and sediment of the Msunduzi river, Kwazulu-Natal, South Africa. Environ Tox, Vol.35,No 1, pp. 36-46.
Aherne, G. W., English, J., Marks, V. (1985). The role of immunoassay in the analysis of microcontaminants in water samples. Ecotox Environ Safety 9, 79–83.
Akande, T. M., Ologo, M. O. (2007). Prescription Pattern at a Secondary Health Care Facility in Ilorin, Nigeria. Annals of African Medicine 6 (4): 186 – 189.
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